Victory Capital Management Inc Fibrogen Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 11,828 shares of FGEN stock, worth $4,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,828

Previous 11,942 0.95%

Holding current value

$4,139

Previous $10,000 60.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$0.33 - $1.26 $37 - $143	-114 Reduced 0.95%	11,828 $4,000
Q2 2024 Aug 05, 2024	BUY	$0.89 - $2.36 $10,628 - $28,183	11,942 New	11,942 $10,000
Q1 2023 May 02, 2023	BUY	$15.95 - $25.18 $106,546 - $168,202	6,680 Added 13.28%	56,980 $1.06 Million
Q4 2022 Feb 10, 2023	SELL	$13.27 - $17.73 $128,705 - $171,963	-9,699 Reduced 16.17%	50,300 $805,000
Q4 2022 Feb 09, 2023	BUY	$13.27 - $17.73 $211,908 - $283,130	15,969 Added 36.27%	59,999 $961,000
Q3 2022 Nov 02, 2022	BUY	$11.4 - $14.6 $501,942 - $642,838	44,030 New	44,030 $573,000
Q1 2022 May 04, 2022	SELL	$12.02 - $16.79 $121,594 - $169,847	-10,116 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$9.93 - $15.39 $1,638 - $2,539	-165 Reduced 1.6%	10,116 $143,000
Q3 2021 Nov 02, 2021	BUY	$10.18 - $26.64 $2,687 - $7,032	264 Added 2.64%	10,281 $105,000
Q2 2021 Aug 03, 2021	SELL	$18.57 - $35.68 $8,932 - $17,162	-481 Reduced 4.58%	10,017 $267,000
Q1 2021 May 04, 2021	SELL	$31.0 - $55.72 $19,592 - $35,215	-632 Reduced 5.68%	10,498 $364,000
Q4 2020 Feb 01, 2021	BUY	$37.09 - $48.97 $18,582 - $24,533	501 Added 4.71%	11,130 $413,000
Q3 2020 Nov 09, 2020	SELL	$40.47 - $45.5 $6,394 - $7,189	-158 Reduced 1.46%	10,629 $437,000
Q2 2020 Aug 07, 2020	SELL	$32.57 - $42.83 $30,974 - $40,731	-951 Reduced 8.1%	10,787 $437,000
Q1 2020 May 04, 2020	SELL	$23.3 - $45.96 $28,169 - $55,565	-1,209 Reduced 9.34%	11,738 $408,000
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $30,707 - $42,677	888 Added 7.36%	12,947 $555,000
Q4 2019 Feb 04, 2020	BUY	$34.58 - $48.06 $9,336 - $12,976	270 Added 2.29%	12,059 $505,000
Q3 2019 Nov 12, 2019	BUY	$36.98 - $48.45 $360,591 - $472,435	9,751 Added 478.46%	11,789 $436,000
Q2 2019 Aug 15, 2019	SELL	$35.13 - $55.53 $137,850 - $217,899	-3,924 Reduced 65.82%	2,038 $92,000
Q1 2019 May 03, 2019	SELL	$42.83 - $59.91 $226,913 - $317,403	-5,298 Reduced 47.05%	5,962 $324,000
Q4 2018 May 02, 2019	BUY	$37.97 - $60.16 $427,542 - $677,401	11,260 New	11,260 $521,000
Q2 2018 Aug 02, 2018	SELL	$44.9 - $64.95 $505,574 - $731,337	-11,260 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$33.4 - $53.9 $376,084 - $606,914	11,260	11,260 $606,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Fibrogen Inc Transaction History